1. Home
  2. AUR vs ASND Comparison

AUR vs ASND Comparison

Compare AUR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$7.08

Market Cap

14.2B

Sector

Technology

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$247.96

Market Cap

14.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUR
ASND
Founded
2017
2006
Country
United States
Denmark
Employees
1900
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
14.7B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
AUR
ASND
Price
$7.08
$247.96
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$9.43
$281.50
AVG Volume (30 Days)
29.5M
643.1K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$407.30
$96.35
Revenue Next Year
$1,134.58
$44.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$156.56
52 Week High
$8.57
$250.74

Technical Indicators

Market Signals
Indicator
AUR
ASND
Relative Strength Index (RSI) 57.84 59.56
Support Level $5.17 $215.18
Resistance Level $8.57 N/A
Average True Range (ATR) 0.55 9.56
MACD -0.09 1.04
Stochastic Oscillator 30.00 92.11

Price Performance

Historical Comparison
AUR
ASND

About AUR Aurora Innovation Inc.

Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: